The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.

Video on Dry Eyeeye_pic.jpg

In recent years the nosology of Dry Eye has greatly changed. Professor Baudouin, MD, PhD from National Ophthalmologiy Hospital XV-XX, Vision Institute of Paris explains through this didactic video the complexity of the Dry Eye disease. Moving beyond the simple name of Dry Eye syndrome, we now consider the condition to be Dry Eye disease, insisting on the lack of tears, the lacrimal inflammation and hyperevaporation leading to self-sustaining loops of neurogenic and palpebral inflammations.

View the video


The refreshing alternative

VISMED® LIGHT is a multidose contact lens lubricant that offers a cost-effective alternative for long-term relief of mild ocular discomfort during hard or soft contact lens wear.

VISMED® LIGHT is a 0.1% solution of sodium hyaluronate, a natural polymer which is also present in the structures of human eyes.

VISMED® LIGHT has been formulated to be hypotonic to counteract the hyperosmolartity of the tear film in dry eye patients and with essential ions such calcium magnesium and potassium to improve corneal cells physiology.

VISMED® LIGHT is protected by the synergistic association of soft and well-tolerated preservatives.

VISMED® LIGHT is available in multidose containers of 5 and 15 ml.

pdf VISMED® LIGHT leaflet
trb_lock.gif Doctor information

  • English